ISO 10993-17:2002Withdrawn

Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substances

Évaluation biologique des dispositifs médicaux — Partie 17: Établissement des limites admissibles des substances relargables

This edition has been replaced by ISO 10993-17:2023.

Abstract / scope

ISO 10993-17:2002 specifies the determination of allowable limits for substances leachable from medical devices. It is intended for use in deriving standards and estimating appropriate limits where standards do not exist. It describes a systematic process through which identified risks arising from toxicologically hazardous substances present in medical devices can be quantified.

ISO 10993-17:2002 is not applicable to devices that have no patient contact (e.g. in vitro diagnostic devices).

Exposure to a particular chemical substance may arise from sources other than the device, such as food, water or air. ISO 10993-17:2002 does not address the potential for exposure from such sources.

Life cycle

Replaced by

ISO/PWI 10993-17Deleted (project abandoned)Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substancesInternational Standard · ISO/TC 194ISO 10993-17:2023PublishedBiological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituentsInternational Standard · Published 13 Sep 2023 · ISO/TC 194